Zolgensma Archives - Express Pharma

EMA seeks to issue guidance on liver damage from Novartis’s gene therapy

Biogen to study Spinraza in combination with $2-mn Novartis drug

Roche’s SMA drug trial win bolsters $2 billion sales prospects

Novartis’ Zolgensma study halted by FDA amid safety questions